Free Trial

ImmuPharma (IMM) News Today

GBX 2.24
-0.16 (-6.67%)
(As of 05/20/2024 ET)
ImmuPharma PLC IMM
ImmuPharma PLC (25I.SG)
ImmuPharma shares jump 6.5% after FDA update
ImmuPharama eyes clinical trial progress
ImmuPharma eyes clinical trial progress
ImmuPharma "looking forward" to upcoming FDA meetings
ImmuPharma partner gets FDA meeting date
ImmuPharma rises 4% after it reveals headway with lead asset
ImmuPharma expects new Lupozor study to begin in H2 2023
ImmuPharma Shares Rise After Lupuzor Trial Confirmed
ImmuPharma partner agrees phase II/III clinical trial process
UK data highlights oncoming recession
ImmuPharma plc (IMM.L)
Get ImmuPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter.

**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report

IMM Media Mentions By Week

IMM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMM
News Sentiment

0.00

0.42

Average
Medical
News Sentiment

IMM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMM Articles
This Week

0

0

IMM Articles
Average Week

Get ImmuPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:IMM) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners